Table 3.
Characteristic | n | % | |
---|---|---|---|
Breasts affected | Unilateral | 25 | 83.3 |
Bilateral | 5 | 16.7 | |
Days from reconstruction to infection | Mean | 49.5 | NA |
Median | 23 | NA | |
Range | 7–420 | NA | |
White cell count at presentation | Mean | 9.0 | NA |
Median | 7.9 | NA | |
Range | 1.8–24.7 | NA | |
Not requested | 3 | 10 | |
C-Reactive protein at presentation (mg/L) | Mean | 75.0 | NA |
Median | 37.0 | NA | |
Range | 2–380 | NA | |
Not requested | 2 | 6.7 | |
Organisms identified on culture | MSSA* | 9 | 30.0 |
Serratia marcescens | 4 | 13.3 | |
MRSA† | 2 | 6.7 | |
Pseudomonas aeurginosa | 2 | 6.7 | |
Multiple organisms | 3 | 10.0 | |
Other organisms± | 6 | 20.0 | |
No growth | 1 | 3.3 | |
Unknown§ | 3 | 10.0 |
*methicillin-sensitive Staphylococcus aureus.
†methicillin-resistant Staphylococcus aureus.
±Brevibacterium casei, Corynebacterium imitans, Enterococcus faecalis, Staphylococcus haemolyticus, Klebsiella oxytoca, and Proteus mirabilis.
§Not retrieved from review of medical record.